These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32299366)

  • 21. Multipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing.
    Schiedat F; Schöne D; Aweimer A; Bösche L; Ewers A; Gotzmann M; Patsalis PC; Mügge A; Kloppe A
    Clin Res Cardiol; 2020 Feb; 109(2):183-193. PubMed ID: 31152199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study.
    Dauphin R; Nonin E; Bontemps L; Vincent M; Pinel A; Bonijoly S; Barborier D; Ribier A; Fernandes CM; Bert-Marcaz P; Itti R; Chevalier P
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):114-21. PubMed ID: 21239562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel electrocardiographic dyssynchrony criteria improve patient selection for cardiac resynchronization therapy.
    Vereckei A; Szelényi Z; Kutyifa V; Zima E; Szénási G; Kiss M; Katona G; Karádi I; Merkely B
    Europace; 2018 Jan; 20(1):97-103. PubMed ID: 28011802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices.
    Poulidakis E; Aggeli C; Sideris S; Sfendouraki E; Koutagiar I; Katsaros A; Giannoulis E; Koukos M; Margioula E; Lagoudakou S; Gatzoulis K; Dilaveris P; Kallikazaros I; Couloheri S; Stefanadis C; Tousoulis D
    Int J Cardiovasc Imaging; 2019 Feb; 35(2):285-294. PubMed ID: 30623352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of patients with and without super-response to CRT-D.
    Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
    Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of serum metabolomics analysis in predicting the response to cardiac resynchronization therapy.
    Zhu MR; Fulati Z; Liu Y; Wang WS; Wu Q; Su YG; Chen HY; Shu XH
    J Geriatr Cardiol; 2019 Jul; 16(7):529-539. PubMed ID: 31447892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy.
    Vecera J; Penicka M; Eriksen M; Russell K; Bartunek J; Vanderheyden M; Smiseth OA
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):624-32. PubMed ID: 26921169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.
    Imamura T; Kinugawa K; Nitta D; Komuro I
    Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.
    Obrzut S; Tiongson J; Jamshidi N; Phan HM; Hoh C; Birgersdotter-Green U
    J Cardiovasc Transl Res; 2010 Dec; 3(6):643-51. PubMed ID: 20842468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy - a pilot study.
    Kuznetsov VA; Soldatova AM; Kasprzak JD; Krinochkin DV; Melnikov NN
    Cardiovasc Ultrasound; 2018 Oct; 16(1):24. PubMed ID: 30285762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental Value of Speckle Tracking Echocardiography to Predict Cardiac Resynchronization Therapy (CRT) Responders.
    Seo Y; Ishizu T; Machino-Ohtsuka T; Yamamoto M; Machino T; Kuroki K; Yamasaki H; Sekiguchi Y; Nogami A; Aonuma K
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response.
    Sultan A; Wörmann J; Lüker J; V D Bruck J-; Plenge T; Rudolph V; Klinke A; Heijman J; Mollenhauer M; Ravekes T; Baldus S; Steven D
    Clin Res Cardiol; 2021 Aug; 110(8):1173-1180. PubMed ID: 32564144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate.
    Sardu C; Paolisso P; Sacra C; Santamaria M; de Lucia C; Ruocco A; Mauro C; Paolisso G; Rizzo MR; Barbieri M; Marfella R
    Cardiovasc Diabetol; 2018 Oct; 17(1):137. PubMed ID: 30348145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of paced left ventricular dyssynchrony on left ventricular reverse remodeling after cardiac resynchronization therapy.
    Gauthey A; Willemen E; Lumens J; Ploux S; Bordachar P; Ritter P; Prinzen FW; Lejeune S; Pouleur AC; Garnir Q; Marchandise S; Scavée C; Wauters A; le Polain de Waroux JB
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):494-502. PubMed ID: 31908084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction in heart failure identifies responders to cardiac resynchronization therapy.
    Akar JG; Al-Chekakie MO; Fugate T; Moran L; Froloshki B; Varma N; Santucci P; Wilber DJ; Matsumura ME
    Heart Rhythm; 2008 Sep; 5(9):1229-35. PubMed ID: 18774094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
    Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
    Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine Learning Prediction of Response to Cardiac Resynchronization Therapy: Improvement Versus Current Guidelines.
    Feeny AK; Rickard J; Patel D; Toro S; Trulock KM; Park CJ; LaBarbera MA; Varma N; Niebauer MJ; Sinha S; Gorodeski EZ; Grimm RA; Ji X; Barnard J; Madabhushi A; Spragg DD; Chung MK
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007316. PubMed ID: 31216884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.
    Qiu Q; Chen YX; Mai JT; Yuan WL; Wei YL; Liu YM; Yang L; Wang JF
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):329-37. PubMed ID: 25392055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.